Oculoplastics

Introducing Dr. Kami Parsa's Cutting-Edge Training Course: A Modern-Day Approach to Surgical Lower Eyelid Rejuvenation

Retrieved on: 
Tuesday, June 27, 2023

BEVERLY HILLS, Calif., June 27, 2023 /PRNewswire-PRWeb/ -- Core Aesthetics is proud to announce the launch of an innovative training course led by renowned expert Dr. Kami Parsa, designed to revolutionize the field of lower eyelid surgical rejuvenation. The course features training on a modern surgical eyelid rejuvenation procedure called "Trifecta Lift" and will take place on Saturday, October 21, 2023, from 8:00 am to 11:00 am via Zoom. This comprehensive educational program offers medical professionals a unique opportunity to master advanced techniques and gain invaluable insights into achieving exceptional outcomes in lower eyelid procedures.

Key Points: 
  • Dr. Kami Parsa, a renowned expert in aesthetic and oculoplastic surgery, proudly announces a comprehensive training course on his signature approach to surgical lower eyelid and periocular rejuvenation.
  • One of his signature surgical techniques for lower eyelid rejuvenation is his "Trifecta Lift" procedure, which involves lower eyelid blepharoplasty, micro fat transfer, canthal suspension and skin tightening.
  • "Lower eyelid surgical rejuvenation is an intricate procedure that requires a delicate balance of artistry and technical expertise," said Dr. Parsa.
  • The training course is open to ophthalmologists, plastic surgeons, dermatologists, and other medical professionals with a keen interest in lower eyelid surgical rejuvenation.

Introducing Skinuva Bruise: Pharmaceutical Grade, Physician Developed Homeopathic Supplement

Retrieved on: 
Wednesday, August 17, 2022

BEVERLY HILLS, Calif., Aug. 17, 2022 /PRNewswire/ --Skinuva is excited to announce the launch of its newest physician developed and solutions driven product, Skinuva Bruise.

Key Points: 
  • BEVERLY HILLS, Calif., Aug. 17, 2022 /PRNewswire/ --Skinuva is excited to announce the launch of its newest physician developed and solutions driven product, Skinuva Bruise.
  • Skinuva Bruise is the perfect addition to expand the Skinuva portfolio as a clinically supported homeopathic supplement to aid in recovery.
  • Skinuva Bruise is a pharmaceutical grade, homeopathic supplement that includes the best ingredients known to aid healing and reduce the appearance of bruising including Arnica Montana, Bromelain, Zinc, Vitamin C, Grape Seed Extract, and Rutin.
  • "Just as Skinuva Scar and Skinuva Brite were developed out of a desire to offer more scientifically based and clinically proven topical products for scars and hyperpigmentation, we also developed Skinuva Bruise to be a more safe and effective homeopathic post-recovery supplement.

Sight Sciences Announces the Appointment of Tamara Fountain, M.D. to its Board of Directors

Retrieved on: 
Tuesday, July 19, 2022

As part of her duties, Dr. Fountain has joined Sight Sciences Nominating and Corporate Governance Committee.

Key Points: 
  • As part of her duties, Dr. Fountain has joined Sight Sciences Nominating and Corporate Governance Committee.
  • Tamara is an accomplished ophthalmologist with both incredible clinical and academic credentials as well as significant ophthalmic leadership experience.
  • She will provide Sight Sciences and our Board of Directors with new and valuable perspectives as we continue to scale our businesses in glaucoma and ocular surface disease, said Paul Badawi, co-founder and Chief Executive Officer of Sight Sciences.
  • Sight Sciences is an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients lives.

Allergan Aesthetics publishes 'The Future of Aesthetics' global trends report providing unrivalled insight into future of industry

Retrieved on: 
Friday, June 17, 2022

IRVINE, Calif., June 17, 2022 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, and a global leader in medical aesthetics treatments, today launched 'The Future of Aesthetics' global trends report via a high-profile virtual event for media and industry. Commissioned by Allergan Aesthetics and independently developed by specialist trend forecasting agency Wunderman Thompson Intelligence, the report aims to help the industry understand the developments driving today's aesthetics market, and to highlight the key trends that may shape it in the years ahead.

Key Points: 
  • -- Built on robust market research and analysis of global social listening data, industry research, academic studies, and Allergan Aesthetics* proprietary global research into thousands of consumer attitudes1 --
    IRVINE, Calif., June 17, 2022 /PRNewswire/ --Allergan Aesthetics, an AbbVie company, and a global leader in medical aesthetics treatments, today launched 'The Future of Aesthetics' global trends report via a high-profile virtual event for media and industry.
  • The report builds on our 2019 research Allergan 360 Aesthetics Report about evolving global beauty perceptions and priorities6and reaffirms our commitment to innovative science and the future growth of the market.
  • Dr Chantrey, commented; "I'm proud to be a part of the launch of 'The Future of Aesthetics' global trends report - a must-read for anyone interested or involved in the aesthetics industry.
  • It charts emerging and future global trends, consumer change, and innovation patternstranslating these into insight for brands.

Prevent Blindness Declares Second Annual Thyroid Eye Disease (TED) Awareness Week to Help Educate the Public on Risk Factors, Symptoms, and Resources for Care

Retrieved on: 
Wednesday, November 10, 2021

CHICAGO, Nov. 10, 2021 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's oldest nonprofit eye health and safety organization, has declared Nov. 14-20, 2021 as the second annual "Thyroid Eye Disease Awareness (TED) Week."

Key Points: 
  • CHICAGO, Nov. 10, 2021 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's oldest nonprofit eye health and safety organization, has declared Nov. 14-20, 2021 as the second annual "Thyroid Eye Disease Awareness (TED) Week."
  • Additionally, Prevent Blindness will debut its newest episode in the Focus on Eye Health Expert Series , "Thyroid Eye Disease" featuring Dr. Sara Wester, Associate Professor of Clinical Ophthalmology, Bascom Palmer Eye Institute , TED specialist and Oculoplastic Surgeon.
  • Thyroid Eye Disease (TED), sometimes called Graves' ophthalmopathy or Graves' Eye Disease, is an autoimmune disease in which the immune system causes inflammation and swelling and stimulates the production of muscle tissue and fat behind the eye.
  • While TED often occurs in people living with hyperthyroidism or Graves' disease, TED is a distinct disease requiring separate treatment.

New TEPEZZA® (teprotumumab-trbw) Data to be Presented at the American Academy of Ophthalmology (AAO) 2021 Annual Meeting

Retrieved on: 
Tuesday, October 12, 2021

Horizon Therapeutics plc (Nasdaq: HZNP) today announced new TEPEZZA data will be presented at the American Academy of Ophthalmology Annual Meeting ( AAO 2021 ) in New Orleans and virtually, Nov. 12-15, 2021.

Key Points: 
  • Horizon Therapeutics plc (Nasdaq: HZNP) today announced new TEPEZZA data will be presented at the American Academy of Ophthalmology Annual Meeting ( AAO 2021 ) in New Orleans and virtually, Nov. 12-15, 2021.
  • Infusion reactions have been reported in approximately 4% of patients treated with TEPEZZA.
  • Signs and symptoms may include transient increases in blood pressure, feeling hot, tachycardia, dyspnea, headache and muscular pain.
  • Preexisting Inflammatory Bowel Disease: TEPEZZA may cause an exacerbation of preexisting inflammatory bowel disease (IBD).

Eye Health America Acquires Nielsen Eye Center

Retrieved on: 
Friday, August 27, 2021

Eye Health America (EHA) is proud to announce the acquisition of Nielsen Eye Center.

Key Points: 
  • Eye Health America (EHA) is proud to announce the acquisition of Nielsen Eye Center.
  • Nielsen Eye Center is joining Updegraff Laser Vision to expand Eye Health Americas continuum of patient care in the Tampa Bay area.
  • Nielsen Eye Center has two offices: 2339 Sunset Point Rd Ste 300, Clearwater, FL 33765 and 8787 Bryan Dairy Rd Ste 260, Largo, FL 33777.
  • Member practices include Clemson Eye, Piedmont Surgery Center, The Surgery & Laser Center, Carolinas Centers for Sight, Florence Surgery and Laser Center, Pee Dee Eye Associates, The Eye Associates, Updegraff Laser Vision and Tampa Bay Eye Surgery Center, and many other top eyecare providers in the Southeastern U.S.

Eye Expert Dr. Ami Shah Vira Joins Exclusive Haute Beauty Network

Retrieved on: 
Monday, August 16, 2021

CEDAR PARK, Texas, Aug. 16, 2021 /PRNewswire-PRWeb/ -- Dr. Shah Vira is an eyelid and oculoplastics expert, board-certified in ophthalmology, and fellowship-trained in oculoplastics.

Key Points: 
  • CEDAR PARK, Texas, Aug. 16, 2021 /PRNewswire-PRWeb/ -- Dr. Shah Vira is an eyelid and oculoplastics expert, board-certified in ophthalmology, and fellowship-trained in oculoplastics.
  • As an oculoplastic surgeon, Dr. Shah Vira is committed to giving every patient fantastic, natural, and lasting results.
  • As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.
  • For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/
    Alana Garcia, Haute Beauty by Haute Living, 4074864288, [email protected]

Yukon Supports Ridgemont and Sunvera Group’s Partnership with TruVista Surgery Center

Retrieved on: 
Tuesday, June 22, 2021

Yukon Partners (Yukon), a provider of mezzanine capital for middle market private equity transactions, is pleased to announce its support of Sunvera Group (Sunvera), a management services organization providing support services to ophthalmology practices across multiple subspecialties as well as ophthalmic-focused ambulatory surgery centers, in its partnership with TruVista Surgery Center.

Key Points: 
  • Yukon Partners (Yukon), a provider of mezzanine capital for middle market private equity transactions, is pleased to announce its support of Sunvera Group (Sunvera), a management services organization providing support services to ophthalmology practices across multiple subspecialties as well as ophthalmic-focused ambulatory surgery centers, in its partnership with TruVista Surgery Center.
  • The center and its staff are committed to giving their patients a personalized experience as they go through the surgery process.
  • The AAAHC-certified center consists of four large operating suites and is focused on ophthalmic and oculoplastic surgery.
  • Adding TruVista to the Sunvera family is a testament to that commitment, said Greg Nodland, CEO of Sunvera Group.

Prominent Beverly Hills Oculoplastic Surgeon, Dr. Kami Parsa, Debuts New 7th Generation VISIA® Complexion Analysis System

Retrieved on: 
Tuesday, November 10, 2020

BEVERLY HILLS, Calif., Nov. 10, 2020 /PRNewswire-PRWeb/ --Dr. Kami Parsa is well-known for his expertise in aesthetic and oculoplastic surgery , earning numerous awards as a top Beverly Hills' plastic surgeon.

Key Points: 
  • BEVERLY HILLS, Calif., Nov. 10, 2020 /PRNewswire-PRWeb/ --Dr. Kami Parsa is well-known for his expertise in aesthetic and oculoplastic surgery , earning numerous awards as a top Beverly Hills' plastic surgeon.
  • Believing that everyone deserves access to premier skincare and facial rejuvenation technology, he has recently acquired the state-of-the-art, 7th Generation VISIA Complexion Analysis System by Canfield Scientific, Inc.
  • The all-new VISIA Complexion Analysis System uses multi-spectral images and analysis of the skin, giving a clear, multi-dimensional insight into the individual aspects of a patient's complexion.
  • For more information on the new VISIA Complexion Analysis System or other cosmetic and reconstructive options offered by Dr. Kami Parsa, please call his Beverly Hills clinic and MedSpa at (310) 777-8880, or visit his website at http://www.oculoplastic.info .